About Dren Bio
Dren Bio is a company based in San Carlos (United States) founded in 2019 by John Wesley and Nenad Tomasevic.. Dren Bio has raised $131 million across 3 funding rounds from investors including Pfizer, ARE and Revelation Partners. Dren Bio operates in a competitive market with competitors including Moderna, Horizon Therapeutics, Forge Biologics, argenx and Annexon, among others.
- Headquarter San Carlos, United States
- Founders John Wesley, Nenad Tomasevic
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$131 M (USD)
in 3 rounds
-
Latest Funding Round
$65 M (USD), Series B
Mar 28, 2022
-
Investors
Pfizer
& 10 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Dren Bio
Dren Bio has successfully raised a total of $131M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $65 million completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $65.0M
-
First Round
First Round
(01 Jun 2019)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2022 | Amount | Series B - Dren Bio | Valuation | Aisling Capital , HBM Healthcare Investments | |
| Sep, 2020 | Amount | Series A - Dren Bio | Valuation | SR One , Taiho Ventures | |
| Jun, 2019 | Amount | Seed - Dren Bio | Valuation | 8VC |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Dren Bio
Dren Bio has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Pfizer, ARE and Revelation Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PE firm investing in the US
|
Founded Year | Domain | Location | |
|
Life sciences focused VC firm funding companies in the US and Europe
|
Founded Year | Domain | Location | |
|
A biotechnology venture capital firm investing in innovative science.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Dren Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Dren Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Dren Bio Comparisons
Competitors of Dren Bio
Dren Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Horizon Therapeutics, Forge Biologics, argenx and Annexon, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for treating rare and autoimmune diseases
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases are developed to treat patients.
|
|
| domain | founded_year | HQ Location |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment.
|
|
| domain | founded_year | HQ Location |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
|
| domain | founded_year | HQ Location |
Therapeutics for autoimmune diseases are developed by the company.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Dren Bio
Frequently Asked Questions about Dren Bio
When was Dren Bio founded?
Dren Bio was founded in 2019.
Where is Dren Bio located?
Dren Bio is headquartered in San Carlos, United States. It is registered at San Carlos, California, United States.
Who is the current CEO of Dren Bio?
Nenad Tomasevic is the current CEO of Dren Bio. They have also founded this company.
Is Dren Bio a funded company?
Dren Bio is a funded company, having raised a total of $131M across 3 funding rounds to date. The company's 1st funding round was a Seed of $6M, raised on Jun 01, 2019.
What does Dren Bio do?
Dren Bio was founded in 2019 and is headquartered in San Carlos, United States. Antibodies are developed for treating cancer, autoimmune conditions, and other serious diseases within the biotechnology sector. Operations focus on candidates like DR-01, a nonfucosylated antibody for hematologic malignancies, and DR-0201, a targeted myeloid engager using a phagocytosis platform for B cell malignancies.
Who are the top competitors of Dren Bio?
Dren Bio's top competitors include Moderna, argenx and Forge Biologics.
Who are Dren Bio's investors?
Dren Bio has 11 investors. Key investors include Pfizer, ARE, Revelation Partners, HBM Healthcare Investments, and ArrowMark Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.